Inhibitors for treatment of hematological malignancies

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

MRÁZ Marek ŠEDA Václav ONDRIŠOVÁ Laura

Year of publication 2023
Type Patent
MU Faculty or unit

Central European Institute of Technology

Publisher United States Patent and Trademark Office
State United States of America
Patent's number US11648255B2
Web Link na PDF dokument na stránkách Google Patents
Description A new approach to treatment of hematological malignancies. A GAB1 inhibitor for use in a method of treatment of a hematological malignancy is disclosed. The GAB1 inhibitor may be administered alone, or simultaneously or sequen-tially with a BTK inhibitor to achieve a synergistic effect.

You are running an old browser version. We recommend updating your browser to its latest version.

More info